Transdel's topical pain hope gets mixed Phase III results
This article was originally published in Scrip
Executive Summary
Transdel Pharmaceuticals' only product candidate, Ketotransdel (ketoprofen), relieved pain safely and effectively in the per-protocol population, but not in the intent-to-treat one, show top-line Phase III results.